CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 15, 2024 · earnings

IKT earnings: a positive outcome, +29.2%

On May 15, 2024, Inhibikase Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +29.2% in the window around the event. It had already run -40.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1.54
1d before
$1.99
Event day
$1.76
1d after
$1.86
5d after

Pre-catalyst setup

-40.2%
30-day run-up
16709%
30-day volatility
0.8×
volume spike